...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: got this & sent a response/follow up minutes before …

"Answer: FINRA created a “ZHCLF” symbol and linked it with Zenith’s CUSIP #, and trades under the symbol “ZHCLF” have taken place on the OTC Grey Market*. This was/is completely out of Zenith’s control. For the avoidance of doubt, Zenith was/is not involved in any trading in ZHCLF on the OTC Grey Market."

So yes there the same but the company sure has a hard time saying it clearly imo??

Share
New Message
Please login to post a reply